Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$318K Buy
879
+136
+18% +$46.6K 0.03% 242
2026
Q1
$261K Buy
743
+43
+6% +$15.3K 0.03% 247
2025
Q4
$229K Sell
700
-455
-39% -$144K 0.02% 285
2025
Q3
$326K Sell
1,155
-1,574
-58% -$456K 0.03% 202
2025
Q2
$762K Buy
2,729
+636
+30% +$180K 0.09% 78
2025
Q1
$652K Buy
+2,093
New +$618K 0.08% 79

Other funds holding AMGN

SYM Financial Corp's AMGN Position: Q2 2026 in Review

SYM Financial Corp increased its Amgen (AMGN) stake by 18% in Q2 2026, buying an estimated $46.6K and bringing the position to 879 shares worth $318K. The position accounts for 0.03% of the portfolio, ranked #242.

SYM Financial Corp first reported a position in AMGN in Q1 2025 and has held it in 6 quarters since. The position peaked at $762K in Q2 2025. 3,157 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • SYM Financial Corp held 879 shares of Amgen worth $318K as of Q2 2026.
  • SYM Financial Corp bought 136 Amgen shares in Q2 2026, an estimated $46.6K.
  • Amgen made up 0.03% of SYM Financial Corp's portfolio in Q2 2026, its #242 holding.
  • SYM Financial Corp first reported a position in Amgen in Q1 2025 and has held it in 6 quarters since.
  • SYM Financial Corp's Amgen position peaked at $762K in Q2 2025.
  • 3,157 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on SYM Financial Corp's 13F filing for Q2 2026, filed 4 Aug 2026.